Problems related to the use of Anabolic Androgenic Steroids (AAS) by practitioners of weight training and the role of the pharmacist in education of these athletes in order to reduce indiscriminate use
Abstract
The seeking for the perfect body is assuming alarming proportions among the world. The cult of the body triggered a frantic search for devices designed to achieve ideal beauty unrealistic for most people. Among these artifacts, we highlight the use of anabolic androgenic steroids (AAS), which have similar effects of testosterone, increasing the force of contraction and the volume of muscle cells. The pharmacist as professional duly qualified drugs, fits into this context decisively, assuming the role of “health educator”, and explaining to users (or prospective users) about the risks inherent in such a practice, acting decisively in discouraging the use of AAS in drugstores when faced with individual’s intent on making non-medical use/illicit AAS, looking always flee from traditional approaches that awareness campaigns (that few results have been obtained in recent years).
Keywords
Testosterone; pharmacy; anabolic, academy
Full Text:
PDF (Português (Brasil))DOI: http://dx.doi.org/10.14450/2318-9312.v25.e3.a2013.pp143-154
Refbacks
- There are currently no refbacks.
Copyright (c) 2014 Infarma - Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Infarma - Ciências Farmacêuticas
ISSN - 2318-9312 (Versão eletrônica)
ISSN - 0104-0219 (Versão impressa)
Conselho Federal de Farmácia - CFF
SHIS QI 15 Lote "L" - Lago Sul - Brasília - DF
CEP: 71635-615 - Fone: (61)3878-8751
e-mail:infarma@cff.org.br
Diretoria
Walter da Silva Jorge João, Presidente do Conselho Federal de Farmácia
Lenira da Silva Costa, Vice-Presidente do Conselho Federal de Farmácia
João Samuel de Morais Meira, Tesoureiro do Conselho Federal de Farmácia
Luiz Gustavo de Freitas Pires, Secretário-Geral do Conselho Federal de Farmácia